PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

Adaptive Biotechnologies Corporation (ADPT)

Equity · Currency in USD · Last updated Dec 7, 2023
SummaryFinancials

Company Info

ISINUS00650F1093
CUSIP00650F109
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$36.95M
EPS$0.14
PE Ratio81.14
EBITDA (TTM)-$171.43M
Year Range$10.16 - $15.18
Target Price$9.17

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of $10,000 in Adaptive Biotechnologies Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%10.00%JulyAugustSeptemberOctoberNovemberDecember
-39.56%
6.61%
ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ADPT

Adaptive Biotechnologies Corporation

Popular comparisons: ADPT vs. SPY

Return

Adaptive Biotechnologies Corporation had a return of -39.53% year-to-date (YTD) and -41.00% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-39.53%18.49%
1 month-3.75%4.20%
6 months-39.53%6.60%
1 year-41.00%15.43%
5 years (annualized)N/A11.59%
10 years (annualized)N/A9.70%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-2.52%-3.59%25.78%-19.79%-19.50%-18.53%-1.35%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for Adaptive Biotechnologies Corporation (ADPT) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ADPT
Adaptive Biotechnologies Corporation
-0.58
^GSPC
S&P 500
1.00

Sharpe Ratio

The current Adaptive Biotechnologies Corporation Sharpe ratio is -0.58. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00JulyAugustSeptemberOctoberNovemberDecember
-0.58
1.00
ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)

Dividend History


Adaptive Biotechnologies Corporation doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-93.18%
-5.15%
ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Adaptive Biotechnologies Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Adaptive Biotechnologies Corporation was 94.90%, occurring on Nov 13, 2023. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-94.9%Jan 25, 2021707Nov 13, 2023
-68.3%Sep 5, 2019133Mar 16, 2020188Dec 10, 2020321
-27.29%Jul 1, 201925Aug 5, 201918Aug 29, 201943
-14.85%Dec 24, 20207Jan 5, 20217Jan 14, 202114
-2.05%Dec 15, 20201Dec 15, 20202Dec 17, 20203

Volatility Chart

The current Adaptive Biotechnologies Corporation volatility is 34.71%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%JulyAugustSeptemberOctoberNovemberDecember
34.71%
2.92%
ADPT (Adaptive Biotechnologies Corporation)
Benchmark (^GSPC)